A property investment finance company is seeking judgment for €1.19m against businessman Paddy McKillen jnr over a guarantee ...

Health care apps like MyChart, mySugr, GoodRx, and Smoke Free can enhance patient care through accessibility, convenience, ...

In recent years, smartwatches and smart rings have grown increasingly popular, adorning the wrists and fingers of consumers who use them to monitor their exercise, sleep and heart ...

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Abbott (NYSE:ABT) today announced a significant milestone abroad with the opening of a new manufacturing facility in Ireland.

First announced in August 2022, the 30,000-square metre facility will have the world’s highest production of sensors used in ...

Abbott's Freestyle Libre 2 and 3 are the first CGMs to receive FDA clearance for use during imaging tests like X-rays, CT ...

The online fundraiser event also includes a special opportunity to purchase this year's 20th anniversary commemorative ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

That large bottom-line miss overshadowed the company's robust top-line growth. But could this pullback actually be a golden opportunity to buy into a high-growth stock that's still up nearly 40% over ...

Executive Editor David Carnoy has been a leading member of CNET's Reviews team since 2000. He covers the gamut of gadgets and is a notable reviewer of mobile accessories and portable audio ...